Earflo announced that it received FDA clearance for its non-invasive device designed to treat negative middle ear pressure in ...

Earflo, a medical technology company pioneering non-invasive pediatric ear care, today announced the U.S. market availability of its FDA-cleared device designed to treat negative middle ear pressure ...

What Is Otarmeni, and Why Does It Matter? Otarmeni (lunsotogene parvec-cwha) is a single-use gene therapy for children and adults who have severe or profound hearing loss (a hearing level of more than ...

Optical coherence tomography (OCT), a tool routinely used to diagnose and plan treatment for eye diseases, has now been modified to collect images of the inner ear. "These findings are exciting ...

A gene therapy developed with the help of Harvard Medical School researchers restored hearing in 90 percent of patients with ...